Correspondence 0001493152-23-002715 from Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc.
Date: Jan. 27, 2023 · CIK: 0001757499 · Accession: 0001493152-23-002715
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-269414
Letter
Via EDGAR Division of Corporation Finance Office of Life Sciences Attention: Daniel Crawford Re: Shuttle Pharmaceuticals Holdings, Inc. Registration Statement on Form S-1 (File No. 333-269414) Withdraw of Acceleration Request
Dear Mr. Crawford:
Reference is made to our letter, filed as correspondence via EDGAR on January 25, 2023, in which the registrant, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), requested the acceleration of the effective date of the above referenced Registration Statement on Form S-1 (the “Registration Statement”) for 5 pm Eastern Time on Friday, January 27, 2023, or as soon thereafter as reasonably practicable (the “Effective Time”), in accordance with Rule 460 and 461 under the Securities Act of 1933, as amended.
The Company is no longer requesting that such Registration Statement be declared effective at the Effective Time and we hereby formally withdraw our request for acceleration of the effective date until further notice from the Company.
Very
truly yours,
SHUTTLE
PHARMACEUTICALS HOLDINGS, INC.
Show Raw Text
CORRESP
1
filename1.htm
January
27, 2023
Via
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
D.C. 20549-3720
Attention:
Daniel
Crawford
Re:
Shuttle
Pharmaceuticals Holdings, Inc.
Registration
Statement on Form S-1 (File No. 333-269414)
Withdraw
of Acceleration Request
Dear
Mr. Crawford:
Reference
is made to our letter, filed as correspondence via EDGAR on January 25, 2023, in which the registrant, Shuttle Pharmaceuticals Holdings,
Inc., a Delaware corporation (the “Company”), requested the acceleration of the effective date of the above referenced
Registration Statement on Form S-1 (the “Registration Statement”) for 5 pm Eastern Time on Friday, January
27, 2023, or as soon thereafter as reasonably practicable (the “Effective Time”), in accordance with Rule 460 and
461 under the Securities Act of 1933, as amended.
The
Company is no longer requesting that such Registration Statement be declared effective at the Effective Time and we hereby formally withdraw
our request for acceleration of the effective date until further notice from the Company.
Very
truly yours,
SHUTTLE
PHARMACEUTICALS HOLDINGS, INC.
By:
/s/
Anatoly Dritschilo
Anatoly
Dritschilo, M.D.
Chief
Executive Officer
cc: Megan J. Penick,
Esq.,
Michelman & Robinson,
LLP